Skip to the content
Please enable JavaScript in your browser to complete this form.
Thank you for attending the BioMarin sponsored symposium at the ICIEM 2021 Transforming Rare Diseases Congress. Please take a moment to complete this, anonymous evaluation survey.
*
required
Please could you indicate your geographical location?
*
Australia
Asia Pacific Region
North America
Latin America
Europe
How would you rate the overall quality of the symposium?
*
Excellent
Very good
Good
Satisfactory
Poor
Please rate the following aspects of the symposium.
Agenda and flow
*
Excellent
Very good
Good
Satisfactory
Poor
Excellent
Item #1 Excellent
Very good
Item #1 Very good
Good
Item #1 Good
Satisfactory
Item #1 Satisfactory
Poor
Item #1 Poor
Talk titled: Cognitive, Psychiatric and MRI changes in adults who improve Phe control
*
Excellent
Very good
Good
Satisfactory
Poor
Excellent
Item #1 Excellent
Very good
Item #1 Very good
Good
Item #1 Good
Satisfactory
Item #1 Satisfactory
Poor
Item #1 Poor
Talk titled: Clinical experience aiming for physiological Phe
*
Excellent
Very good
Good
Satisfactory
Poor
Excellent
Item #1 Excellent
Very good
Item #1 Very good
Good
Item #1 Good
Satisfactory
Item #1 Satisfactory
Poor
Item #1 Poor
Duration of speaker talks
*
Excellent
Very good
Good
Satisfactory
Poor
Excellent
Item #1 Excellent
Very good
Item #1 Very good
Good
Item #1 Good
Satisfactory
Item #1 Satisfactory
Poor
Item #1 Poor
Q&A discussion
*
Excellent
Very good
Good
Satisfactory
Poor
Excellent
Item #1 Excellent
Very good
Item #1 Very good
Good
Item #1 Good
Satisfactory
Item #1 Satisfactory
Poor
Item #1 Poor
Please describe which aspect(s) of the symposium you found the most interesting?
*
Please confirm if you would like to receive further information from BioMarin programs on topics relating to this symposium:
Confirm
I confirm I am at least 18 years old; and confirm I agree to BioMarin’s
Privacy Policy
and
Terms of Use
; consent to BioMarin, its successors, agents, and/or assigns using the email address I have provided to keep me informed about diagnosis and management of rare diseases; and confirm I understand these communications/materials may contain information that markets or advertises BioMarin products, goods, or services.
First Name
*
Last Name
*
Email
*
Submit